Drug Reference
Palivizumab
Antiviral monoclonal antibodies
Fact box
- Therapeutic class
- Antiviral monoclonal antibodies
- Action class
- Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
- Mechanism
- Fusion Protein Inhibitors
- Chemical class
- Antibodies, Monoclonal
- Habit forming
- No
Brand names
Synagis
Available as
1 ML · Injection0.5 ML · Injection
No structured FDA label was available. Use the authoritative links below.
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.